Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.

Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, López-Jiménez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, Gaidano G, Lee JJ, Abhyankar S, Solano C, Perez de Oteyza J, Satlin MJ, Schwartz S, Campins M, Rocci A, Vallejo Llamas C, Lee DG, Tan SM, Johnston AM, Grigg A, Boeckh MJ, Campora L, Lopez-Fauqued M, Heineman TC, Stadtmauer EA, Sullivan KM; ZOE-HSCT Study Group Collaborators.

JAMA. 2019 Jul 9;322(2):123-133. doi: 10.1001/jama.2019.9053.

PMID:
31287523
2.

Usefulness of echocardiographic McConnell's sign in the computerized-medicine-era.

Siniscalchi C, Palumbo A, Rocci A, Basaglia M, Gaibazzi N.

Acta Cardiol. 2019 Jan 16:1-2. doi: 10.1080/00015385.2018.1507304. [Epub ahead of print] No abstract available.

PMID:
30648927
3.

Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.

Gambella M, Omedé P, Spada S, Muccio VE, Gilestro M, Saraci E, Grammatico S, Larocca A, Conticello C, Bernardini A, Gamberi B, Troia R, Liberati AM, Offidani M, Rocci A, Palumbo A, Cavo M, Sonneveld P, Boccadoro M, Oliva S.

Cancer. 2019 Mar 1;125(5):750-760. doi: 10.1002/cncr.31854. Epub 2018 Dec 18.

PMID:
30561775
4.

Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations.

Swan D, Rocci A, Bradbury C, Thachil J.

Br J Haematol. 2018 Nov;183(4):538-556. doi: 10.1111/bjh.15684. Epub 2018 Nov 18. Review.

PMID:
30450656
5.

Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy.

Otero R, Bertoletti L, Muriel A, Siniscalchi C, Jimenez C, Luis Lobo J, Kigitovica D, Quintavalla R, Rocci A, Jara-Palomares L, Monreal M; RIETE Investigators.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702576. doi: 10.1183/13993003.02576-2017. Print 2018 Apr. No abstract available.

PMID:
29496752
6.

The Schmidt Syndrome.

Siniscalchi C, Moretti V, Cataldo S, Rocci A, Basaglia M, Tassoni MI, Quintavalla R.

Acta Biomed. 2018 Jan 16;88(4):499-501. doi: 10.23750/abm.v88i4.5117.

7.

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.

Glavey SV, Naba A, Manier S, Clauser K, Tahri S, Park J, Reagan MR, Moschetta M, Mishima Y, Gambella M, Rocci A, Sacco A, O'Dwyer ME, Asara JM, Palumbo A, Roccaro AM, Hynes RO, Ghobrial IM.

Leukemia. 2017 Nov;31(11):2426-2434. doi: 10.1038/leu.2017.102. Epub 2017 Mar 27.

PMID:
28344315
8.

Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM.

J Exp Med. 2017 May 1;214(5):1557. doi: 10.1084/jem.2012095001172017c. Epub 2017 Jan 19. No abstract available.

9.

IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma.

Bolomsky A, Hübl W, Spada S, Müldür E, Schlangen K, Heintel D, Rocci A, Weißmann A, Fritz V, Willheim M, Zojer N, Palumbo A, Ludwig H.

Am J Hematol. 2017 Mar;92(3):269-278. doi: 10.1002/ajh.24634. Epub 2017 Feb 1.

10.

Different performance of platform switching in equicrestal position implant: an histological study.

Rocci A, Calcaterra R, Rocci M, Rocci C, DI Girolamo M, Baggi L.

Oral Implantol (Rome). 2016 Nov 13;9(1):11-16. doi: 10.11138/orl/2016.9.1.011. eCollection 2016 Jan-Mar.

11.

The influence of micro and macro-geometry in term of bone-implant interface in two implant systems: an histomorphometrical study.

Rocci A, Calcaterra R, DI Girolamo M, Rocci M, Rocci C, Baggi L.

Oral Implantol (Rome). 2016 Jul 23;8(4):87-95. doi: 10.11138/orl/2015.8.4.087. eCollection 2015 Oct-Dec.

12.

Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysis.

Oliva S, Gambella M, Gilestro M, Muccio VE, Gay F, Drandi D, Ferrero S, Passera R, Pautasso C, Bernardini A, Genuardi M, Patriarca F, Saraci E, Petrucci MT, Pescosta N, Liberati AM, Caravita T, Conticello C, Rocci A, Musto P, Boccadoro M, Palumbo A, Omedè P.

Oncotarget. 2017 Jan 24;8(4):5924-5935. doi: 10.18632/oncotarget.12641.

13.

Atypical And Severe Enlargement Of Right Atrium.

Siniscalchi C, Rossetti P, Rocci A, Rubino P, Basaglia M, Gaibazzi N, Quintavalla R.

Acta Biomed. 2016 Sep 13;87(2):191-3.

PMID:
27649002
14.

Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.

Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM.

Cancer Cell. 2016 Aug 8;30(2):349-351. doi: 10.1016/j.ccell.2016.07.007. Epub 2016 Aug 8. No abstract available.

15.

Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers.

Harshman SW, Canella A, Ciarlariello PD, Agarwal K, Branson OE, Rocci A, Cordero H, Phelps MA, Hade EM, Dubovsky JA, Palumbo A, Rosko A, Byrd JC, Hofmeister CC, Benson DM Jr, Paulaitis ME, Freitas MA, Pichiorri F.

J Proteomics. 2016 Mar 16;136:89-98. doi: 10.1016/j.jprot.2015.12.016. Epub 2016 Jan 13.

16.

MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?

Gambella M, Palumbo A, Rocci A.

Expert Rev Mol Diagn. 2015;15(7):881-93. doi: 10.1586/14737159.2015.1046436. Epub 2015 May 12. Review.

17.

Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors.

Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C, Capece D, D'Andrea D, Bua M, Boyle E, van Duin M, Zoppoli P, Jaxa-Chamiec A, Thotakura AK, Dyson J, Walker BA, Leonardi A, Chambery A, Driessen C, Sonneveld P, Morgan G, Palumbo A, Tramontano A, Rahemtulla A, Ruvo M, Franzoso G.

Cancer Cell. 2014 Dec 8;26(6):938. doi: 10.1016/j.ccell.2014.11.021. Epub 2014 Dec 8. No abstract available.

18.

Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors.

Tornatore L, Sandomenico A, Raimondo D, Low C, Rocci A, Tralau-Stewart C, Capece D, D'Andrea D, Bua M, Boyle E, van Duin M, Zoppoli P, Jaxa-Chamiec A, Thotakura AK, Dyson J, Walker BA, Leonardi A, Chambery A, Driessen C, Sonneveld P, Morgan G, Palumbo A, Tramontano A, Rahemtulla A, Ruvo M, Franzoso G.

Cancer Cell. 2014 Oct 13;26(4):495-508. doi: 10.1016/j.ccr.2014.07.027. Erratum in: Cancer Cell. 2014 Dec 8;26(6):938.

19.

The potential of miRNAs as biomarkers for multiple myeloma.

Rocci A, Hofmeister CC, Pichiorri F.

Expert Rev Mol Diagn. 2014 Nov;14(8):947-59. doi: 10.1586/14737159.2014.946906. Epub 2014 Aug 7. Review.

PMID:
25098410
20.

Circulating miRNA markers show promise as new prognosticators for multiple myeloma.

Rocci A, Hofmeister CC, Geyer S, Stiff A, Gambella M, Cascione L, Guan J, Benson DM, Efebera YA, Talabere T, Dirisala V, Smith EM, Omedè P, Isaia G, De Luca L, Rossi D, Gentili S, Uccello G, Consiglio J, Ria R, Benevolo G, Bringhen S, Callea V, Weiss B, Ferro A, Magarotto V, Alder H, Byrd JC, Boccadoro M, Marcucci G, Palumbo A, Pichiorri F.

Leukemia. 2014 Sep;28(9):1922-6. doi: 10.1038/leu.2014.155. Epub 2014 May 12. No abstract available.

21.

A prospective cohort study on the impact of smoking on soft tissue alterations around single implants.

Raes S, Rocci A, Raes F, Cooper L, De Bruyn H, Cosyn J.

Clin Oral Implants Res. 2015 Sep;26(9):1086-90. doi: 10.1111/clr.12405. Epub 2014 May 5.

PMID:
24798293
22.

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib.

Gambella M, Rocci A, Passera R, Gay F, Omedè P, Crippa C, Corradini P, Romano A, Rossi D, Ladetto M, Boccadoro M, Palumbo A.

Haematologica. 2014 Feb;99(2):e14-6. doi: 10.3324/haematol.2013.090142. No abstract available.

23.

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients.

Rocci A, Gambella M, Aschero S, Baldi I, Trusolino L, Cavallo F, Gay F, Larocca A, Magarotto V, Omedè P, Isaia G, Bertotti A, Liberati AM, Catalano L, De Rosa L, Musto P, Vallone R, Falcone A, Drandi D, Ladetto M, Comoglio PM, Boccadoro M, Palumbo A.

Br J Haematol. 2014 Mar;164(6):841-50. doi: 10.1111/bjh.12719. Epub 2014 Jan 23.

24.

Characterization of multiple myeloma vesicles by label-free relative quantitation.

Harshman SW, Canella A, Ciarlariello PD, Rocci A, Agarwal K, Smith EM, Talabere T, Efebera YA, Hofmeister CC, Benson DM Jr, Paulaitis ME, Freitas MA, Pichiorri F.

Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.

25.

Immediate loading of Brånemark system TiUnite and machined-surface implants in the posterior mandible, part II: a randomized open-ended 9-year follow-up clinical trial.

Rocci A, Rocci M, Rocci C, Scoccia A, Gargari M, Martignoni M, Gottlow J, Sennerby L.

Int J Oral Maxillofac Implants. 2013 May-Jun;28(3):891-5. doi: 10.11607/jomi.2397.

PMID:
23748324
26.

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

Pichiorri F, Palmieri D, De Luca L, Consiglio J, You J, Rocci A, Talabere T, Piovan C, Lagana A, Cascione L, Guan J, Gasparini P, Balatti V, Nuovo G, Coppola V, Hofmeister CC, Marcucci G, Byrd JC, Volinia S, Shapiro CL, Freitas MA, Croce CM.

J Exp Med. 2013 May 6;210(5):951-68. doi: 10.1084/jem.20120950. Epub 2013 Apr 22. Erratum in: J Exp Med. 2017 May 1;214(5):1557.

27.

High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone.

Heintel D, Rocci A, Ludwig H, Bolomsky A, Caltagirone S, Schreder M, Pfeifer S, Gisslinger H, Zojer N, Jäger U, Palumbo A.

Br J Haematol. 2013 Jun;161(5):695-700. doi: 10.1111/bjh.12338. Epub 2013 Apr 9.

PMID:
23565715
28.

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.

Bonanno G, Mariotti A, Procoli A, Folgiero V, Natale D, De Rosa L, Majolino I, Novarese L, Rocci A, Gambella M, Ciciarello M, Scambia G, Palumbo A, Locatelli F, De Cristofaro R, Rutella S.

J Transl Med. 2012 Dec 11;10:247. doi: 10.1186/1479-5876-10-247.

29.
30.

Lenalidomide-prednisone induction followed by lenalidomide-melphalan-prednisone consolidation and lenalidomide-prednisone maintenance in newly diagnosed elderly unfit myeloma patients.

Falco P, Cavallo F, Larocca A, Rossi D, Guglielmelli T, Rocci A, Grasso M, Siez ML, De Paoli L, Oliva S, Molica S, Mina R, Gay F, Benevolo G, Musto P, Omedè P, Freilone R, Bringhen S, Carella AM, Gaidano G, Boccadoro M, Palumbo A.

Leukemia. 2013 Mar;27(3):695-701. doi: 10.1038/leu.2012.271. Epub 2012 Sep 21.

PMID:
22996335
31.

Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.

Lobetti-Bodoni C, Ferrero D, Genuardi E, Passera R, Bernocco E, Sia D, Grignani G, Crisà E, Monitillo L, Rocci A, Drandi D, Giai V, Zanni M, Boi M, Isaia G, Barbero D, Lunghi M, Abruzzese E, Radaelli F, Pini M, Pregno P, Carlo-Stella C, Gaidano G, Boccadoro M, Ladetto M.

Mech Ageing Dev. 2012 Jul;133(7):479-88. doi: 10.1016/j.mad.2012.05.007. Epub 2012 Jun 9.

PMID:
22687638
32.

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Ross FM, Avet-Loiseau H, Ameye G, Gutiérrez NC, Liebisch P, O'Connor S, Dalva K, Fabris S, Testi AM, Jarosova M, Hodkinson C, Collin A, Kerndrup G, Kuglik P, Ladon D, Bernasconi P, Maes B, Zemanova Z, Michalova K, Michau L, Neben K, Hermansen NE, Rack K, Rocci A, Protheroe R, Chiecchio L, Poirel HA, Sonneveld P, Nyegaard M, Johnsen HE; European Myeloma Network.

Haematologica. 2012 Aug;97(8):1272-7. Epub 2012 Feb 27.

33.

Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations.

Agnelli L, Storti P, Todoerti K, Sammarelli G, Dalla Palma B, Bolzoni M, Rocci A, Piazza F, Semenzato G, Palumbo A, Neri A, Giuliani N.

Am J Hematol. 2011 Dec;86(12):E64-6. doi: 10.1002/ajh.22164. Epub 2011 Sep 22.

34.

Brain abscess of odontogenic origin in a man with interatrial defect.

Milli B, Rocci A, Paganelli E, Degli Antoni G, Monaco D, Quintavalla R.

Acta Biomed. 2010 Dec;81(3):225-9.

PMID:
22530461
35.

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development.

Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM.

Cancer Cell. 2010 Oct 19;18(4):367-81. doi: 10.1016/j.ccr.2010.09.005. Erratum in: Cancer Cell. 2016 Aug 8;30(2):349-351.

36.

European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.

Engelhardt M, Udi J, Kleber M, Spencer A, Rocci A, Knop S, Bruno B, Bringhen S, Pérez-Simón JA, Zweegman S, Driessen C, Patriarca F, Gramatzki M, Terpos E, Sezer O, Kropff M, Straka C, Johnsen HE, Waage A, Boegsted M, Lokhorst H, Hájek R, Morgan G, Boccadoro M, Ludwig H, Cavo M, Polliack A, Sonneveld P, Einsele H, Palumbo A.

Leuk Lymphoma. 2010 Nov;51(11):2006-11. doi: 10.3109/10428194.2010.516378. Epub 2010 Aug 31. Review.

37.

Compound heterozygosity for two new TERT mutations in a patient with aplastic anemia.

Aspesi A, Vallero S, Rocci A, Pavesi E, Lanciotti M, Ramenghi U, Dianzani I.

Pediatr Blood Cancer. 2010 Sep;55(3):550-3. doi: 10.1002/pbc.22589.

PMID:
20658629
38.

Biological response of human bone marrow mesenchymal stem cells to fluoride-modified titanium surfaces.

Guida L, Annunziata M, Rocci A, Contaldo M, Rullo R, Oliva A.

Clin Oral Implants Res. 2010 Nov;21(11):1234-41. doi: 10.1111/j.1600-0501.2010.01929.x. Epub 2010 Aug 19.

PMID:
20497444
39.

Bone osteoblastic and mesenchymal stromal cells lack primarily tumoral features in multiple myeloma patients.

Giuliani N, Lisignoli G, Novara F, Storti P, Zaffaroni N, Villa R, Sammarelli G, Agnelli L, Todoerti K, Bernardo ME, Manferdini C, Colla S, Abeltino M, Bolzoni M, Rocci A, Gabusi E, Palumbo A, Zuffardi O, Neri A, Rizzoli V.

Leukemia. 2010 Jul;24(7):1368-70. doi: 10.1038/leu.2010.96. Epub 2010 May 20. No abstract available.

PMID:
20485369
40.

Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status.

Ruella M, Rocci A, Ricca I, Carniti C, Bodoni CL, Ladetto M, Caracciolo D, Boccadoro M, Carlo-Stella C, Corradini P, Tarella C.

Bone Marrow Transplant. 2010 Mar;45(3):505-12. doi: 10.1038/bmt.2009.297. Epub 2009 Oct 19.

PMID:
19838219
41.

Analysis of telomeres in peripheral blood cells from patients with bone marrow failure.

Pavesi E, Avondo F, Aspesi A, Quarello P, Rocci A, Vimercati C, Pigullo S, Dufour C, Ramenghi U, Dianzani I.

Pediatr Blood Cancer. 2009 Sep;53(3):411-6. doi: 10.1002/pbc.22107.

PMID:
19489057
42.

Management of coronary artery disease in a severe haemophilia patient with high titre inhibitor and anaphylaxis.

Rivolta GF, Di Perna C, Franchini M, Ippolito L, Maurizio AR, Rocci A, Tagliaferri A.

Haemophilia. 2009 Sep;15(5):1161-3. doi: 10.1111/j.1365-2516.2009.02050.x. Epub 2009 May 26. No abstract available.

PMID:
19486169
43.

Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia.

Rossi D, Lobetti Bodoni C, Genuardi E, Monitillo L, Drandi D, Cerri M, Deambrogi C, Ricca I, Rocci A, Ferrero S, Bernocco E, Capello D, De Paoli L, Bergui L, Boi M, Omedè P, Massaia M, Tarella C, Passera R, Boccadoro M, Gaidano G, Ladetto M.

Leukemia. 2009 Jun;23(6):1062-72. doi: 10.1038/leu.2008.399. Epub 2009 Apr 2.

PMID:
19340005
44.

Treating maxillary horizontal atrophies with particulate homologous bone grafts: a case report.

Rocci A, Rocci M, Lattanzio D, Gargari M.

Oral Implantol (Rome). 2009 Jan;2(1):11-8. Epub 2009 Dec 10.

45.

Comparing the TiOblast and Osseospeed surfaces. Histomorphometric and histological analysis in humans.

Rocci M, Rocci A, Martignoni M, Albrektsson T, Barlattani A, Gargari M.

Oral Implantol (Rome). 2008 Apr;1(1):34-42. Epub 2008 Jun 16.

46.

Short-term clinical results of Nobel Direct implants: a retrospective multicentre analysis.

Sennerby L, Rocci A, Becker W, Jonsson L, Johansson LA, Albrektsson T.

Clin Oral Implants Res. 2008 Mar;19(3):219-26. doi: 10.1111/j.1600-0501.2007.01410.x.

PMID:
18237314
47.

Survival of NobelDirect implants: an analysis of 550 consecutively placed implants at 18 different clinical centers.

Albrektsson T, Gottlow J, Meirelles L, Ostman PO, Rocci A, Sennerby L.

Clin Implant Dent Relat Res. 2007 Jun;9(2):65-70.

PMID:
17535329
48.

Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir.

Rocci A, Ricca I, Dellacasa C, Longoni P, Compagno M, Francese R, Lobetti Bodoni C, Manzini P, Caracciolo D, Boccadoro M, Ferrero D, Ladetto M, Carlo-Stella C, Tarella C.

Exp Hematol. 2007 Apr;35(4):673-81.

PMID:
17379077
49.

Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.

Ricca I, Rocci A, Drandi D, Francese R, Compagno M, Lobetti Bodoni C, De Marco F, Astolfi M, Monitillo L, Vallet S, Calvi R, Ficara F, Omedè P, Rosato R, Gallamini A, Marinone C, Bergui L, Boccadoro M, Tarella C, Ladetto M.

Leukemia. 2007 Apr;21(4):697-705. Epub 2007 Feb 15.

PMID:
17301820
50.

Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations.

Ladetto M, Mantoan B, De Marco F, Drandi D, Aguzzi C, Astolfi M, Vallet S, Ricca I, Dell' Aquila M, Pagliano G, Monitillo L, Pollio B, Santo L, Cristiano C, Rocci A, Francese R, Bodoni CL, Borchiellini A, Schinco P, Boccadoro M, Tarella C.

Exp Hematol. 2006 Dec;34(12):1680-6.

PMID:
17157165

Supplemental Content

Support Center